Tuesday, May 17, 2022 1:05:32 PM
I think Venkat bought this ticker because he thinks this new acne topical treatment has the potential to be very sucessful. If I remember correctly, the Vyome website states that Phase 2 was successfully completed in June of 2020 (almost 2 years ago). I fail to find any evidence that Phase 3 testing has begun. (Sucessful Phase 3 required before FDA approval).
If anyone contacts Venkat or their CFO (Craig Tooman?), the best question is to ask them is the status of the Phase 3 trial. Successful Phase 3 trial is the lynchpin of this ticker.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM